3 ms·
From the press release: "If this funding challenge is met in gifts, grants, and multi-year pledges, MAPS will have raised sufficient funds to complete its Phas
by noahdesu 9y ago
From the press release:
"If this funding challenge is met in gifts, grants, and multi-year pledges, MAPS will have raised sufficient funds to complete its Phase 3 trials."
That statement is huge. The idea that MAPS has successfully taken a compound through the entire FDA approval process using only donations is kinda amazing. They received breakthrough status with the FDA, they are starting phase 3 trials, and the only thing holding them back is an amount of money that would be a drop in the bucket for a big pharma company.